FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2805364487> ?p ?o ?g. }

• W2805364487 endingPage "200" @default.
• W2805364487 startingPage "189" @default.
• W2805364487 abstract "Seasonal malaria chemoprevention (SMC) using sulfadoxine–pyrimethamine plus amodiaquine has been introduced in 12 African countries. Additional strategies for safety monitoring are needed to supplement national systems of spontaneous reporting that are known to under represent the incidence of adverse reactions. This study aimed to determine if adverse event (AE) reporting could be improved using a smartphone application provided to village health workers, or by active follow-up using a symptom card provided to caregivers. Two strategies to improve reporting of AEs during SMC campaigns were evaluated, in comparison with the national system of spontaneous reporting, in 11 health post areas in Senegal. In each health post, an average of approximately 4000 children under 10 years of age received SMC treatment each month for 3 months during the 2015 malaria transmission season—a total of 134,000 treatments. In three health posts (serving approximately 14,000 children), caregivers were encouraged to report any adverse reactions to the nurse at the health post or to a community health worker (CHW) in their village, who had been trained to use a smartphone application to report the event (enhanced spontaneous reporting). In two health posts (approximately 10,000 children), active follow-up of children at home was organized after each SMC campaign to ask about AEs that caregivers had been asked to record on a symptom card (active surveillance). Six health posts (approximately 23,000 children) followed the national system of spontaneous reporting using the national reporting (yellow) form. Each AE report was assessed by a panel to determine likely association with SMC drugs. The incidence of reported AEs was 2.4, 30.6, and 21.6 per 1000 children treated per month, using the national system, enhanced spontaneous reporting, and active surveillance, respectively. The most commonly reported symptoms were vomiting, fever, and abdominal pain. The incidence of vomiting, known to be caused by amodiaquine, was similar using both innovative methods (10/1000 in the first month, decreasing to 2.5/1000 in the third month). Despite increased surveillance, no serious adverse drug reactions were detected. Training CHWs in each village and health facility staff to report AEs using a mobile phone application led to much higher reporting rates than through the national system. This approach is feasible and acceptable, and could be further improved by strengthening laboratory investigation and the collection of control data immediately prior to SMC campaigns." @default.
• W2805364487 created "2018-06-13" @default.
• W2805364487 creator A5004796559 @default.
• W2805364487 creator A5012776301 @default.
• W2805364487 creator A5016074838 @default.
• W2805364487 creator A5018725432 @default.
• W2805364487 creator A5021349077 @default.
• W2805364487 creator A5028694107 @default.
• W2805364487 creator A5031076825 @default.
• W2805364487 creator A5045944576 @default.
• W2805364487 creator A5054185332 @default.
• W2805364487 creator A5058236091 @default.
• W2805364487 creator A5070980797 @default.
• W2805364487 creator A5076135237 @default.
• W2805364487 creator A5076621207 @default.
• W2805364487 creator A5079016337 @default.
• W2805364487 creator A5086627697 @default.
• W2805364487 creator A5087485589 @default.
• W2805364487 date "2018-06-01" @default.
• W2805364487 modified "2023-10-01" @default.
• W2805364487 title "Evaluation of Two Strategies for Community-Based Safety Monitoring during Seasonal Malaria Chemoprevention Campaigns in Senegal, Compared with the National Spontaneous Reporting System" @default.
• W2805364487 cites W2036003931 @default.
• W2805364487 cites W2057676788 @default.
• W2805364487 cites W2101014303 @default.
• W2805364487 cites W2102316487 @default.
• W2805364487 cites W2111690693 @default.
• W2805364487 cites W2113391705 @default.
• W2805364487 cites W2142960482 @default.
• W2805364487 cites W2168226801 @default.
• W2805364487 cites W2172272315 @default.
• W2805364487 cites W2326927218 @default.
• W2805364487 cites W2536894942 @default.
• W2805364487 cites W4249836150 @default.
• W2805364487 doi "https://doi.org/10.1007/s40290-018-0232-z" @default.
• W2805364487 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6006231" @default.
• W2805364487 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29983573" @default.
• W2805364487 hasPublicationYear "2018" @default.
• W2805364487 type Work @default.
• W2805364487 sameAs 2805364487 @default.
• W2805364487 citedByCount "11" @default.
• W2805364487 countsByYear W28053644872018 @default.
• W2805364487 countsByYear W28053644872020 @default.
• W2805364487 countsByYear W28053644872022 @default.
• W2805364487 countsByYear W28053644872023 @default.
• W2805364487 crossrefType "journal-article" @default.
• W2805364487 hasAuthorship W2805364487A5004796559 @default.
• W2805364487 hasAuthorship W2805364487A5012776301 @default.
• W2805364487 hasAuthorship W2805364487A5016074838 @default.
• W2805364487 hasAuthorship W2805364487A5018725432 @default.
• W2805364487 hasAuthorship W2805364487A5021349077 @default.
• W2805364487 hasAuthorship W2805364487A5028694107 @default.
• W2805364487 hasAuthorship W2805364487A5031076825 @default.
• W2805364487 hasAuthorship W2805364487A5045944576 @default.
• W2805364487 hasAuthorship W2805364487A5054185332 @default.
• W2805364487 hasAuthorship W2805364487A5058236091 @default.
• W2805364487 hasAuthorship W2805364487A5070980797 @default.
• W2805364487 hasAuthorship W2805364487A5076135237 @default.
• W2805364487 hasAuthorship W2805364487A5076621207 @default.
• W2805364487 hasAuthorship W2805364487A5079016337 @default.
• W2805364487 hasAuthorship W2805364487A5086627697 @default.
• W2805364487 hasAuthorship W2805364487A5087485589 @default.
• W2805364487 hasBestOaLocation W28053644871 @default.
• W2805364487 hasConcept C120665830 @default.
• W2805364487 hasConcept C121332964 @default.
• W2805364487 hasConcept C126322002 @default.
• W2805364487 hasConcept C138816342 @default.
• W2805364487 hasConcept C15744967 @default.
• W2805364487 hasConcept C159110408 @default.
• W2805364487 hasConcept C19417346 @default.
• W2805364487 hasConcept C197934379 @default.
• W2805364487 hasConcept C203014093 @default.
• W2805364487 hasConcept C2775949068 @default.
• W2805364487 hasConcept C2776992834 @default.
• W2805364487 hasConcept C2777425658 @default.
• W2805364487 hasConcept C2778048844 @default.
• W2805364487 hasConcept C2781256697 @default.
• W2805364487 hasConcept C2908647359 @default.
• W2805364487 hasConcept C2986740045 @default.
• W2805364487 hasConcept C512399662 @default.
• W2805364487 hasConcept C61511704 @default.
• W2805364487 hasConcept C71924100 @default.
• W2805364487 hasConcept C99454951 @default.
• W2805364487 hasConceptScore W2805364487C120665830 @default.
• W2805364487 hasConceptScore W2805364487C121332964 @default.
• W2805364487 hasConceptScore W2805364487C126322002 @default.
• W2805364487 hasConceptScore W2805364487C138816342 @default.
• W2805364487 hasConceptScore W2805364487C15744967 @default.
• W2805364487 hasConceptScore W2805364487C159110408 @default.
• W2805364487 hasConceptScore W2805364487C19417346 @default.
• W2805364487 hasConceptScore W2805364487C197934379 @default.
• W2805364487 hasConceptScore W2805364487C203014093 @default.
• W2805364487 hasConceptScore W2805364487C2775949068 @default.
• W2805364487 hasConceptScore W2805364487C2776992834 @default.
• W2805364487 hasConceptScore W2805364487C2777425658 @default.
• W2805364487 hasConceptScore W2805364487C2778048844 @default.
• W2805364487 hasConceptScore W2805364487C2781256697 @default.
• W2805364487 hasConceptScore W2805364487C2908647359 @default.
• W2805364487 hasConceptScore W2805364487C2986740045 @default.

• next